Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial
- 1 January 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (1) , 10-17
- https://doi.org/10.1200/jco.2001.19.1.10
Abstract
PURPOSE: Bisphosphonates have effectively reduced the development and progression of bone metastases in advanced breast cancer. The aim of this study was to determine whether bone metastases could ...Keywords
This publication has 22 references indexed in Scilit:
- Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activityBritish Journal of Haematology, 1997
- Apoptosis in phagocytotic cells of lymphoid tissues in rainbow trout ( Oncorhynchus mykiss ) following administration of clodronate liposomesCell and tissue research, 1997
- Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanismJournal of Bone and Mineral Research, 1996
- Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow culturesBone, 1996
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the SkeletonOncology, 1991
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983